Finance

Beta
Lists
BLTE:NASDAQ
Belite Bio Inc
$149.33
-2.55%
(-3.91) 1D
$149.33
0.00% (0.00)
After hours
Closed: Jul 10, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BLTE...
Open
$152.50
High
$154.25
Low
$145.57
Mkt. cap
5.99B
Avg. vol.
252.12K
Volume
153.71K
52-wk high
$200.00
52-wk low
$59.12
EPS
-$2.65
Beta
-1.23
Shares outstanding
39.96M
No. of employees
41
Open
$152.50
High
$154.25
Low
$145.57
Mkt. cap
5.99B
Avg. vol.
252.12K
Volume
153.71K
52-wk high
$200.00
52-wk low
$59.12
EPS
-$2.65
Beta
-1.23
Shares outstanding
39.96M
No. of employees
41
News stories
From sources across the web
About Belite Bio Inc
CEO-
Employees41
Founded2016
Headquarters-
SectorPharmaceutical industry
Websitebelitebio.com
Analyst ratings
Based on 5 analysts giving stock ratings to BLTE in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for BLTE in the last 3 months.
Highest
Current $149.33
$266.00 (+78.13%)
Average
$216.20 (+44.78%)
Lowest
$200.00 (+33.93%)
Analyst
Recommendation
Action
Price target
Projected
Date
Tazeen Ahmad
Bank of America Securities
Buy
Maintained
$200.00
+33.9%
06/15/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
$200.00
+33.9%
06/16/2026
Michael Okunewitch
Maxim Group
Buy
Maintained
$200.00
+33.9%
05/27/2026
Graig Suvannavejh
Mizuho Securities
Buy
Reiterated
$215.00
+44%
05/26/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
$266.00
+78.1%
05/20/2026
Bruce Jackson
Benchmark Co.
Buy
Maintained
$217.00
+45.3%
03/03/2026
Judah Frommer
Morgan Stanley
Buy
Maintained
$201.00
+34.6%
03/03/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
11.05M
10.31M
14.62M
15.66M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.55M
12.71M
13.45M
17.02M
Operating expense
17.60M
23.02M
28.08M
32.68M
Total operating expenses
17.60M
23.02M
28.08M
32.68M
Operating income
-17.60M
-23.02M
-28.08M
-32.68M
Other non operating income
1.28M
-2.14M
-417.00K
5.75M
EBT including unusual items
-16.32M
-21.69M
-25.32M
-26.94M
EBT excluding unusual items
-16.32M
-21.69M
-25.32M
-26.94M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-16.32M
-21.69M
-25.32M
-26.94M
Net profit margin
-
-
-
-
Earnings per share
-0.50
-0.65
-0.70
-0.68
Interest and investment income
-
3.47M
3.17M
-
Interest expense
-
-
-2.00K
-
Net interest expenses
-
3.47M
3.17M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-17.55M
-22.97M
-28.03M
-32.64M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer